Skip Nav Destination
Antibiotics and Chemotherapy
Pseudomonas aeruginosa Infection: International Symposium on Basic Research and Clinical Aspects of Pseudomonas aeruginosa Infection, Copenhagen, September 1988
S.Karger AG
Volume
42
Status:
Available
ISBN electronic:
978-3-318-03217-8
ISBN print:
978-3-8055-5002-4
Discontinued Book Series:
Antibiotics and Chemotherapy
Subject Area:
Further Areas
,
Hematology
,
Immunology and Allergy
,
Oncology
,
Pharmacology
,
Women's and Children's Health
Published online:
2015
Published in print:
1989
Pseudomonas aeruginosa Infection: International Symposium on Basic Research and Clinical Aspects of Pseudomonas aeruginosa Infection, Copenhagen, September 1988
Edited by: N. Hoiby, S. Stenvang Pedersen, G.H. Shand, G. Döring, I.A. Holder
https://doi.org/10.1159/isbn.978-3-318-03217-8
ISBN (print): 978-3-8055-5002-4
ISBN (electronic): 978-3-318-03217-8
Publisher: S.Karger AG
Published: 1989
Download citation file:
Digital Version
Pay-Per-View Access
$282.00
Print Version
Pseudomonas aeruginosa Infection
$282.00
Table of Contents
-
1 - 7: Lipopolysaccharide and Virulence of Pseudomonas aeruginosaByTyrone L. PittTyrone L. PittDivision of Hospital Infection, Central Public Health Laboratory, London, UKSearch for other works by this author on:
-
8 - 14: Pseudomonas aeruginosa Pyoverdin: Structure and FunctionByMohamed A. Abdallah;Mohamed A. AbdallahaLaboratoire de Chimie Organique des Substances Naturelles, UA 31, Département de Chimie, Université Louis-Pasteur, Strasbourg, France;Search for other works by this author on:Martina Pfestorf;Martina PfestorfbHygiene-Institut, University of Tübingen, FRGSearch for other works by this author on:Gerd DöringGerd DöringbHygiene-Institut, University of Tübingen, FRGSearch for other works by this author on:
-
15 - 26: Iron-Regulated Outer Membrane Proteins and Virulence in Pseudomonas aeruginosaByGeoffrey H. Shand;Geoffrey H. ShandaStatens Serum Institute, Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark;Search for other works by this author on:Svend Stenvang Pedersen;Svend Stenvang PedersenaStatens Serum Institute, Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark;Search for other works by this author on:Kan Lam;Kan LambDepartment of Biological Sciences, University of Calgary, CanadaSearch for other works by this author on:Niels HøibyNiels HøibyaStatens Serum Institute, Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark;Search for other works by this author on:
-
27 - 35: Pseudomonas aeruginosa Exoenzyme S as a Pathogenic Determinant in Respiratory InfectionsByDonald E. Woods;Donald E. WoodsDepartment of Microbiology and Infectious Diseases, University of Calgary Health Sciences Center, Faculty of Medicine, Calgary, Alta., CanadaSearch for other works by this author on:Marina To;Marina ToDepartment of Microbiology and Infectious Diseases, University of Calgary Health Sciences Center, Faculty of Medicine, Calgary, Alta., CanadaSearch for other works by this author on:Pamela A. SokolPamela A. SokolDepartment of Microbiology and Infectious Diseases, University of Calgary Health Sciences Center, Faculty of Medicine, Calgary, Alta., CanadaSearch for other works by this author on:
-
36 - 41: Primary Structure of Pseudomonas aeruginosa Elastase: A Comparison with ThermolysinByKazuyuki Morihara;Kazuyuki MoriharaaToho Pharmaceutical Ind., Kyoto Res. Lab., Kyoto, Japan;Search for other works by this author on:Jun Fukushima;Jun FukushimabYokohama City University School of Medicine, Department of Bacteriology, Yokohama, JapanSearch for other works by this author on:Kenji OkudaKenji OkudabYokohama City University School of Medicine, Department of Bacteriology, Yokohama, JapanSearch for other works by this author on:
-
42 - 49: Interactions of Pseudomonas aeruginosa Proteases with the Cells of the Immune SystemByArsalan KharazmiArsalan KharazmiDepartment of Clinical Microbiology, Statens Seruminstitut, Rigshospitalet, Copenhagen, DenmarkSearch for other works by this author on:
-
50 - 55: Bacterial Exopolysaccharides — Their Nature and ProductionByI. W. SutherlandI. W. SutherlandDepartment of Microbiology, Edinburgh University, Edinburgh, UKSearch for other works by this author on:
-
56 - 61: Genetic Regulation of Alginate Structure in Pseudomonas aeruginosaByDennis E. Ohman;Dennis E. OhmanDepartment of Microbiology and Immunology, University of California, Berkeley, Calif., USASearch for other works by this author on:Chetan E. ChitnisChetan E. ChitnisDepartment of Microbiology and Immunology, University of California, Berkeley, Calif., USASearch for other works by this author on:
-
62 - 66: Physicochemical Properties of Alginate from Mucoid Strains of Pseudomonas aeruginosa Isolated from Cystic Fibrosis PatientsByN. J. Russell;N. J. RussellDepartment of Biochemistry, University of Wales College of Cardiff, UKSearch for other works by this author on:P. GacesaP. GacesaDepartment of Biochemistry, University of Wales College of Cardiff, UKSearch for other works by this author on:
-
67 - 71: Bacterial AlginasesByPeter Gacesa;Peter GacesaDepartment of Biochemistry, University of Wales College of Cardiff, UKSearch for other works by this author on:Richard C. Caswell;Richard C. CaswellDepartment of Biochemistry, University of Wales College of Cardiff, UKSearch for other works by this author on:Peter KillePeter KilleDepartment of Biochemistry, University of Wales College of Cardiff, UKSearch for other works by this author on:
-
72 - 79: Role of Alginate in the Adherence of Pseudomonas aeruginosaByNeil R. Baker;Neil R. BakeraDepartment of Microbiology, The Ohio State University, Columbus, Ohio, USA;Search for other works by this author on:Catharina Svanborg-EdénCatharina Svanborg-EdénbDepartment of Clinical Immunology, University of Göteborg, SwedenSearch for other works by this author on:
-
80 - 87: Immunologic Properties of Pseudomonas aeruginosa Mucoid Exopolysaccharide (Alginate)ByGerald B. PierGerald B. PierChanning Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass., USASearch for other works by this author on:
-
88 - 96: Alginate and AntibioticsByJohn R. W. GovanJohn R. W. GovanDepartment of Bacteriology, University of Edinburgh Medical School Edinburgh, UKSearch for other works by this author on:
-
97 - 102: Clinical Features and Pathology of BurnsByBent Sørensen;Bent SørensenDepartment of Plastic Surgery and Burns Unit, Hvidovre Hospital, University of Copenhagen, DenmarkSearch for other works by this author on:Mogens ThomsenMogens ThomsenDepartment of Plastic Surgery and Burns Unit, Hvidovre Hospital, University of Copenhagen, DenmarkSearch for other works by this author on:
-
103 - 108: Pseudomonas aeruginosa: A Controlled Burn Pathogen?1ByA. T. McManusA. T. McManusUS Army Institute of Surgical Research, Fort Sam Houston, San Antonio, Tex., USASearch for other works by this author on:
-
109 - 123: Pseudomonas Hyperimmune Globulin: Antibiotic Treatment of Experimental Pseudomonas Sepsis in Burned Mice1ByIan Alan Holder;Ian Alan HolderShriners Bums Institute and Departments of Microbiology, Surgery and Physiology, University of Cincinnati, College of Medicine, Cincinnati, Ohio, USASearch for other works by this author on:Alice N. NeelyAlice N. NeelyShriners Bums Institute and Departments of Microbiology, Surgery and Physiology, University of Cincinnati, College of Medicine, Cincinnati, Ohio, USASearch for other works by this author on:
-
124 - 129: Cross-Infection with Pseudomonas aeruginosa in Danish Cystic Fibrosis PatientsByN. Høiby;N. HøibyStatens Seruminstitut’s Department of Clinical Microbiology, and Pediatric Department G, Rigshospitalet, Copenhagen, DenmarkSearch for other works by this author on:S. Stenvang PedersenS. Stenvang PedersenStatens Seruminstitut’s Department of Clinical Microbiology, and Pediatric Department G, Rigshospitalet, Copenhagen, DenmarkSearch for other works by this author on:
-
130 - 153: Antibody Response to Pseudomonas aeruginosa Antigens in Cystic FibrosisByS. Stenvang Pedersen;S. Stenvang PedersenStatens Seruminstitut, Department of Clinical Microbiology at Rigshospitalet, Copenhagen, DenmarkSearch for other works by this author on:N. Høiby;N. HøibyStatens Seruminstitut, Department of Clinical Microbiology at Rigshospitalet, Copenhagen, DenmarkSearch for other works by this author on:G. H. Shand;G. H. ShandStatens Seruminstitut, Department of Clinical Microbiology at Rigshospitalet, Copenhagen, DenmarkSearch for other works by this author on:T. PresslerT. PresslerStatens Seruminstitut, Department of Clinical Microbiology at Rigshospitalet, Copenhagen, DenmarkSearch for other works by this author on:
-
154 - 157: Immune Complexes and Inflammation in Cystic FibrosisByPeter Oluf SchiøtzPeter Oluf SchiøtzUniversity of Aarhus, DenmarkSearch for other works by this author on:
-
158 - 168: The Imbalance between Granulocyte Neutral Proteases and Antiproteases in Bronchial Secretions from Patients with Cystic Fibrosis1BySusanne SuterSusanne SuterClinique universitaire de Pédiatrie, Geneva, SwitzerlandSearch for other works by this author on:
-
169 - 176: Polymorphonuclear Leukocyte Elastase: Its Effects on the Pathogenesis of Pseudomonas aeruginosa Infection in Cystic FibrosisByGerd DöringGerd DöringHygiene Institute, University of Töbingen, FRGSearch for other works by this author on:
-
177 - 183: Safety and Immunogenicity of a Polyvalent Pseudomonas aeruginosa O-Polysaccharide-Toxin A Vaccine in HumansByS. J. Cryz;S. J. CryzaSwiss Serum and Vaccine Institute, Berne, Switzerland;Search for other works by this author on:J. C. Sadoff;J. C. SadoffbWalter Reed Army Institute of Research, Washington, D.C., USASearch for other works by this author on:A. S. Cross;A. S. CrossbWalter Reed Army Institute of Research, Washington, D.C., USASearch for other works by this author on:E. FürerE. FüreraSwiss Serum and Vaccine Institute, Berne, Switzerland;Search for other works by this author on:
-
184 - 192: Pseudomonas Immune Globulin Therapy Improves Survival in Experimental Pseudomonas aeruginosa Bacteremic PneumoniaByMichael S. Collins;Michael S. CollinsPreclinical Microbiology. Cutter Biological Division of Miles, Inc., Berkeley, Calif., USASearch for other works by this author on:Alena Edwards;Alena EdwardsPreclinical Microbiology. Cutter Biological Division of Miles, Inc., Berkeley, Calif., USASearch for other works by this author on:Robert E. Roby;Robert E. RobyPreclinical Microbiology. Cutter Biological Division of Miles, Inc., Berkeley, Calif., USASearch for other works by this author on:Nirmal S. Mehton;Nirmal S. MehtonPreclinical Microbiology. Cutter Biological Division of Miles, Inc., Berkeley, Calif., USASearch for other works by this author on:Debra LadehoffDebra LadehoffPreclinical Microbiology. Cutter Biological Division of Miles, Inc., Berkeley, Calif., USASearch for other works by this author on:
-
193 - 202: Pseudomonas aeruginosa Ribosomal Vaccine. A Comparison of the Immunogenicity of Vaccines from Two Different Serotypes1ByMichael M. LiebermanMichael M. LiebermanDepartment of Pathology, William Beaumont Army Medical Center, El Paso, Tex., USASearch for other works by this author on:
-
203 - 209: Genetically Attenuated VaccinesByAnne Morris HookeAnne Morris HookeDepartment of Microbiology, Miami University, Oxford, Ohio, USASearch for other works by this author on:
-
210 - 217: Protection against Experimental Pseudomonas Infection with O Antigen-Specific Human Monoclonal AntibodiesByShuzo Sawada;Shuzo SawadaaTeijin Institute for Biomedical Research, Hino, Tokyo, Japan;Search for other works by this author on:Takashi Kawamura;Takashi KawamuraaTeijin Institute for Biomedical Research, Hino, Tokyo, Japan;Search for other works by this author on:Yasuhiko Masuho;Yasuhiko MasuhoaTeijin Institute for Biomedical Research, Hino, Tokyo, Japan;Search for other works by this author on:Shizuko Iyobe;Shizuko IyobebDepartment of Microbiology, School of Medicine, Gunma University, Maebashi, JapanSearch for other works by this author on:Hajime HashimotoHajime HashimotobDepartment of Microbiology, School of Medicine, Gunma University, Maebashi, JapanSearch for other works by this author on:
-
218 - 228: Studies on a Pseudomonas aeruginosa Flagella VaccineByHeinz Rotering;Heinz RoteringImmuno AG, Biomedical Research Center, Orth/Donau, AustriaSearch for other works by this author on:Friedrich DornerFriedrich DornerImmuno AG, Biomedical Research Center, Orth/Donau, AustriaSearch for other works by this author on:
-
229 - 236: Antibiotic Therapy for Bronchopulmonary Infections in Cystic Fibrosis: The American ApproachByMelvin I. MarksMelvin I. MarksMiller Children’s Hospital, Long Beach, Calif, USASearch for other works by this author on:
-
237 - 246: Use of Antibiotics in Cystic Fibrosis: The Danish ApproachBySvend Stenvang Pedersen;Svend Stenvang PedersenbClinical Microbiology, Rigshospitalet, Copenhagen, DenmarkSearch for other works by this author on:Niels Høiby;Niels HøibybClinical Microbiology, Rigshospitalet, Copenhagen, DenmarkSearch for other works by this author on:Christian Koch;Christian KochaDepartments of Paediatrics andSearch for other works by this author on:Erhard W. FlensburgErhard W. FlensburgaDepartments of Paediatrics andSearch for other works by this author on:
-
247 - 253: Pseudomonas aeruginosa Pneumonia. Treatment with Nonsteroidal Anti-Inflammatory Agents to Prevent Lung Tissue DamageByDaniel O. Sordelli;Daniel O. SordelliDepartamento de Microbiología, Facultad de Mediana, Universidad de Buenos Aires, and Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina de Buenos Aires, ArgentinaSearch for other works by this author on:M. Cristina Cerquetti;M. Cristina CerquettiDepartamento de Microbiología, Facultad de Mediana, Universidad de Buenos Aires, and Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina de Buenos Aires, ArgentinaSearch for other works by this author on:Patricia A. Fontán;Patricia A. FontánDepartamento de Microbiología, Facultad de Mediana, Universidad de Buenos Aires, and Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina de Buenos Aires, ArgentinaSearch for other works by this author on:Verónica E. GarcíaVerónica E. GarcíaDepartamento de Microbiología, Facultad de Mediana, Universidad de Buenos Aires, and Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina de Buenos Aires, ArgentinaSearch for other works by this author on:
-
254 - 256: The Use of Steroids in Cystic FibrosisByHarvey S. AuerbachHarvey S. AuerbachThe Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine, St. Louis, Mo., USASearch for other works by this author on:
-
257 - 263: Role of Beta-Lactamase and Impermeability in the Resistance of Pseudomonas aeruginosaByDavid M. LivermoreDavid M. LivermoreDepartment of Medical Microbiology, The London Hospital Medical College, London, UKSearch for other works by this author on:
-
264 - 274: Beta-Lactamase InhibitorsByPeter A. Lambert;Peter A. LambertPharmaceutical Science Institute, Aston University, Birmingham, UKSearch for other works by this author on:Clare E. SansomClare E. SansomPharmaceutical Science Institute, Aston University, Birmingham, UKSearch for other works by this author on:
-
275 - 286: Intrinsic Resistance of Pseudomonas aeruginosaByCharles W. Stratton;Charles W. StrattonDepartment of Pathology, Vanderbilt University School of Medicine, Nashville, Tenn., USASearch for other works by this author on:Francisca TauskFrancisca TauskDepartment of Pathology, Vanderbilt University School of Medicine, Nashville, Tenn., USASearch for other works by this author on:
-
287 - 300: Mode of Action and Development of Resistance to QuinolonesByWolfgang CullmannWolfgang CullmannDepartment of Medical Microbiology and Immunology, Ruhr-Universität, Bochum, FRGSearch for other works by this author on:
